☆ 4.6 Article

Early Humoral Responses of Hemodialysis Patients After Inactivated SARS-CoV-2 Vaccination

JOURNAL OF INFLAMMATION RESEARCH (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Infectious Diseases

Short-Term Immunogenicity Profiles and Predictors for Suboptimal Immune Responses in Patients with End-Stage Kidney Disease Immunized with Inactivated SARS-CoV-2 Vaccine

Sarinya Boongird et al.

Summary: Patients with end-stage kidney disease (ESKD) had suboptimal humoral immune responses but comparable SARS-CoV-2-specific cell-mediated immune responses to healthy controls after two doses of SARS-CoV-2 vaccination. Old age, high ferritin level, and low absolute lymphocyte count were independently associated with poor humoral immune responses.

INFECTIOUS DISEASES AND THERAPY (2022)

添加到收藏夹

Article Urology & Nephrology

COVID-19 Infection Among US Dialysis Patients: Risk Factors and Outcomes From a National Dialysis Provider

Caroline M. Hsu et al.

AMERICAN JOURNAL OF KIDNEY DISEASES (2021)

添加到收藏夹

Article Medicine, General & Internal

Increased vulnerability to COVID-19 in chronic kidney disease

N. Carlson et al.

Summary: This study found an inverse association between estimated glomerular filtration rate and the rate of hospital-diagnosed COVID-19, as well as a progressive increase in the risk of adverse outcomes with decreasing eGFR levels. These results suggest a vulnerability associated with impaired renal function in relation to COVID-19.

JOURNAL OF INTERNAL MEDICINE (2021)

添加到收藏夹

Article Infectious Diseases

Impact of age, ethnicity, sex and prior infection status on immunogenicity following a single dose of the BNT162b2 mRNA COVID-19 vaccine: real-world evidence from healthcare workers, Israel, December 2020 to January 2021

Kamal Abu Jabal et al.

Summary: An analysis of 514 Israeli healthcare workers showed that the BNT162b2 mRNA COVID-19 vaccine had similar immunogenicity by ethnicity and sex, but decreased with age. Individuals with prior COVID-19 infection had significantly higher antibody titres compared to those who were naive, regardless of pre-vaccination IgG levels.

EUROSURVEILLANCE (2021)

添加到收藏夹

Review Medicine, General & Internal

Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment

Olivier J. Wouters et al.

Summary: The COVID-19 pandemic may not end globally until vaccines that protect against severe disease and drive herd immunity are widely distributed. While vaccines have been authorized for human use in many countries, achieving global control of COVID-19 requires not only licensed vaccines but also mass production, affordable pricing, global allocation, and wide local deployment.

LANCET (2021)

添加到收藏夹

Letter Hematology

Age-dependent and gender-dependent antibody responses against SARS-CoV-2 in health workers and octogenarians after vaccination with the BNT162b2 mRNA vaccine

Evangelos Terpos et al.

AMERICAN JOURNAL OF HEMATOLOGY (2021)

添加到收藏夹

Article Urology & Nephrology

Humoral Response to the Pfizer BNT162b2 Vaccine in Patients Undergoing Maintenance Hemodialysis

Ayelet Grupper et al.

Summary: Patients on maintenance hemodialysis showed a significantly lower humoral response following the BNT162b2 vaccine compared to the control group, with age being an important factor in the humoral response.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2021)

添加到收藏夹

Article Immunology

Antibody Response and Safety After mRNA-1273 SARS-CoV-2 Vaccination in Peritoneal Dialysis Patients - the Vienna Cohort

Georg Beilhack et al.

Summary: The study demonstrated that peritoneal dialysis patients had a high seroconversion rate of 97.4% after receiving the mRNA-1273 vaccine, showing significantly increased antibody titers. The most common adverse events were injection site pain and fatigue, with overall good tolerability of the vaccine.

FRONTIERS IN IMMUNOLOGY (2021)

添加到收藏夹

Editorial Material Transplantation

Antibody response to mRNA SARS-CoV-2 vaccine among dialysis patients-a prospective cohort study

Timna Agur et al.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2021)

添加到收藏夹

Article Transplantation

Haemodialysis patients show a highly diminished antibody response after COVID-19 mRNA vaccination compared with healthy controls

Benedikt Simon et al.

Summary: HD patients had significantly lower anti-SARS-CoV-2 S antibody titres compared to controls 21 days after vaccination. The HD group experienced fewer adverse events than the control group. There was no correlation between the antibody response to Hepatitis B vaccination and the SARS-CoV-2 vaccine.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2021)

添加到收藏夹

Review Medicine, General & Internal

Mini-Review Discussing the Reliability and Efficiency of COVID-19 Vaccines

Bogdan Doroftei et al.

Summary: After analyzing 19 relevant articles, it was concluded that among the eleven vaccines, Pfizer-BioNTech (about 95%), Moderna (about 94%), and Sputnik V (about 92%) showed an efficacy greater than 90%, while Oxford-AstraZeneca was only about 81% effective. Additionally, Moderna, Sputnik V, and Oxford-AstraZeneca also reduced the occurrence of severe adverse reactions.

DIAGNOSTICS (2021)

添加到收藏夹

Article Urology & Nephrology

Early Humoral Responses of Hemodialysis Patients after COVID-19 Vaccination with BNT162b2

Claudius Speer et al.

Summary: Patients receiving long-term hemodialysis show a reduced antibody response to the first and second doses of the mRNA vaccine BNT162b2. The majority (82%) develop neutralizing antibodies after the second dose but at lower levels than healthy controls.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2021)

添加到收藏夹

Article Transplantation

High immunogenicity of a messenger RNA-based vaccine against SARS-CoV-2 in chronic dialysis patients

Nathalie Longlune et al.

Summary: For dialysis patients, the immunogenicity of anti-SARS-CoV-2 mRNA vaccine is high, and a two-dose vaccination is recommended with a possible third dose for non-responders. Patients awaiting kidney transplantation should be offered the vaccine before transplantation.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2021)

添加到收藏夹

Article Medicine, General & Internal

Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile

Alejandro Jara et al.

Summary: A study in Chile involving 10.2 million participants assessed the effectiveness of an inactivated SARS-CoV-2 vaccine developed in China. Fully immunized individuals had vaccine effectiveness of 65.9% for preventing Covid-19 and 87.5% for preventing hospitalization, 90.3% for preventing ICU admission, and 86.3% for preventing death.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Editorial Material Medicine, General & Internal

COVID-19 vaccination and dialysis patients: why the variable response

J-S Yen et al.

Summary: Uremia affects all parts of the immune system, making dialysis patients more susceptible to COVID-19 infection. Different factors such as vaccine types, doses and individual characteristics can lead to varying response rates in dialysis patients. Vaccination against COVID-19 in this population is crucial for global public health.

QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2021)

添加到收藏夹

Article Multidisciplinary Sciences

COVID-19 mRNA vaccine induced antibody responses against three SARS-CoV-2 variants

Pinja Jalkanen et al.

Summary: The study shows that the second dose of the BNT162b2 vaccine can induce cross-neutralization to some extent of SARS-CoV-2 variants, providing partial protection. Despite the reduced neutralization effect on the B.1.351 variant, the majority of vaccinees still have some level of protection.

NATURE COMMUNICATIONS (2021)

添加到收藏夹

Article Medicine, General & Internal

Evaluation of the SARS-CoV-2 Antibody Response to the BNT162b2 Vaccine in Patients Undergoing Hemodialysis

Kevin Yau et al.

Summary: The study indicates poor immunogenicity 28 days after a single dose of the BNT162b2 vaccine in the hemodialysis population, emphasizing the importance of following recommended vaccination schedules and not delaying the second dose in these at-risk individuals.

JAMA NETWORK OPEN (2021)

添加到收藏夹

Editorial Material Immunology

Herd Immunity: Understanding COVID-19

Haley E. Randolph et al.

IMMUNITY (2020)

添加到收藏夹

Letter Urology & Nephrology

Chronic kidney disease is associated with severe coronavirus disease 2019 (COVID-19) infection

Brandon Michael Henry et al.

INTERNATIONAL UROLOGY AND NEPHROLOGY (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Development of an inactivated vaccine candidate for SARS-CoV-2

Qiang Gao et al.

SCIENCE (2020)

添加到收藏夹

Article Medicine, General & Internal

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Fei Zhou et al.

LANCET (2020)

添加到收藏夹

Article Medicine, General & Internal

Remdesivir for the Treatment of Covid-19-Final Report

John H. Beigel et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

添加到收藏夹

Article Immunology

Neutralizing Antibody Responses to Severe Acute Respiratory Syndrome Coronavirus 2 in Coronavirus Disease 2019 Inpatients and Convalescent Patients

Xiaoli Wang et al.

CLINICAL INFECTIOUS DISEASES (2020)

添加到收藏夹

Letter Infectious Diseases

Herd immunity - estimating the level required to halt the COVID-19 epidemics in affected countries

Kin On Kwok et al.

JOURNAL OF INFECTION (2020)

添加到收藏夹

Review Microbiology

Antibody responses to viral infections: a structural perspective across three different enveloped viruses

Charles D. Murin et al.

NATURE MICROBIOLOGY (2019)

添加到收藏夹

Article Biotechnology & Applied Microbiology

A post hoc analysis utilizing the FDA toxicity grading scale to assess injection site adverse events following immunization with the live attenuated Zoster Vaccine (ZVL)

Zoran Popmihajlov et al.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2018)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.